MoneyWorks4Me

Cadila Healthcare informs about disclosure

23 Sep 2021 Evaluate
Cadila Healthcare has informed that it enclosed disclosure in prescribed Form C under Regulation 7[2] of SEBI [Prohibition of Insider Trading] Regulations, 2015, received from Nitin Parekh, Chief Financial Officer of the Company with respect to sale of 10,000 Equity Shares of Re 1 each in the open market.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..